Vismodegib as a Treatment for Multiple Non-locally Advanced Basal Cell Carcinomas

Robert Frantz; Mitchell Herold; Clara Curiel-Lewandrowski

doi:10.25251/skin.6.5.13

Vismodegib as a Treatment for Multiple Non-locally Advanced Basal Cell Carcinomas

Robert Frantz, Mitchell Herold, Clara Curiel-Lewandrowski

Research output: Contribution to journal › Article › peer-review

Abstract

We present the case of a 77-year-old female with seven non-locally advanced basal cell carcinomas (BCCs) of the face who achieved a clinical complete response (CR) in six lesions after completing twelve months of Vismodegib monotherapy with tolerable side effects. This case investigates the off-label practical use of Vismodegib monotherapy to treat multiple non-locally advanced BCCs and reduce the surgical burden of disease in select patients.

Original language	English (US)
Pages (from-to)	421-423
Number of pages	3
Journal	SKIN: Journal of Cutaneous Medicine
Volume	6
Issue number	5
DOIs	https://doi.org/10.25251/skin.6.5.13
State	Published - 2022

ASJC Scopus subject areas

Dermatology

Access to Document

10.25251/skin.6.5.13

Cite this

@article{4bbaaef090b5495c94b867daf12d3591,

title = "Vismodegib as a Treatment for Multiple Non-locally Advanced Basal Cell Carcinomas",

abstract = "We present the case of a 77-year-old female with seven non-locally advanced basal cell carcinomas (BCCs) of the face who achieved a clinical complete response (CR) in six lesions after completing twelve months of Vismodegib monotherapy with tolerable side effects. This case investigates the off-label practical use of Vismodegib monotherapy to treat multiple non-locally advanced BCCs and reduce the surgical burden of disease in select patients.",

author = "Robert Frantz and Mitchell Herold and Clara Curiel-Lewandrowski",

note = "Publisher Copyright: {\textcopyright} 2022 THE AUTHORS.",

year = "2022",

doi = "10.25251/skin.6.5.13",

language = "English (US)",

volume = "6",

pages = "421--423",

journal = "SKIN: Journal of Cutaneous Medicine",

issn = "2574-1624",

publisher = "National Society for Cutaneous Medicine",

number = "5",

}

TY - JOUR

T1 - Vismodegib as a Treatment for Multiple Non-locally Advanced Basal Cell Carcinomas

AU - Frantz, Robert

AU - Herold, Mitchell

AU - Curiel-Lewandrowski, Clara

PY - 2022

Y1 - 2022

N2 - We present the case of a 77-year-old female with seven non-locally advanced basal cell carcinomas (BCCs) of the face who achieved a clinical complete response (CR) in six lesions after completing twelve months of Vismodegib monotherapy with tolerable side effects. This case investigates the off-label practical use of Vismodegib monotherapy to treat multiple non-locally advanced BCCs and reduce the surgical burden of disease in select patients.

AB - We present the case of a 77-year-old female with seven non-locally advanced basal cell carcinomas (BCCs) of the face who achieved a clinical complete response (CR) in six lesions after completing twelve months of Vismodegib monotherapy with tolerable side effects. This case investigates the off-label practical use of Vismodegib monotherapy to treat multiple non-locally advanced BCCs and reduce the surgical burden of disease in select patients.

UR - http://www.scopus.com/inward/record.url?scp=85137903363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137903363&partnerID=8YFLogxK

U2 - 10.25251/skin.6.5.13

DO - 10.25251/skin.6.5.13

M3 - Article

AN - SCOPUS:85137903363

SN - 2574-1624

VL - 6

SP - 421

EP - 423

JO - SKIN: Journal of Cutaneous Medicine

JF - SKIN: Journal of Cutaneous Medicine

IS - 5

ER -

Vismodegib as a Treatment for Multiple Non-locally Advanced Basal Cell Carcinomas

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this